Lactoferrin Nanoparticles as Therapeutic Agent for Infectious Diseases

Authors

  • Prashant Agarwal
  • Ritika Gupta

DOI:

https://doi.org/10.37591/rrjodst.v7i3.1824

Abstract

Lactoferrin (Lf) is a mammalian cationic iron-binding glycoprotein, present in many mammalian excretions and supporting newborn growth to food and pharmaceutical applications. It possesses antibacterial, antimicrobial, antiviral and antiparasitic activity thus, making it an important part of the host defense system. This review focusses on recent therapeutic advances of the natural bioactive protein Lf and its use as a potential treatment agent. Nanoparticles have been tremendously used for several clinical applications preferably as drug delivery system to improve the therapeutic efficacy. Effective conjugation of functionalized agents can improve the binding affinity of nanoparticles to specific areas of the body. Therefore, this property can ensure the protection of bioactive molecules from degradation and enabled prolonged sustainability without severe side-effects. In this study, significant advancements in Lf nanoparticle technology and their use in drug delivery arena have also been reviewed.

 

Keywords: Lactoferrin, nanoparticles, drug delivery, therapeutic

Cite this Article

Prashant Agarwal, Ritika Gupta. Lactoferrin Nanoparticles as Therapeutic Agent for Infectious Diseases. Research and Reviews: Journal of Dairy Science and Technology. 2019; 7(3): 37–40p.

Downloads

Published

2019-03-16

Issue

Vol. 7 No. 3 (2018)

Section

Review Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.